Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.23.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance at Dec. 31, 2021 $ 190,207 $ 15 $ 438,696 $ 732 $ (249,236)
Beginning balance, shares at Dec. 31, 2021   151,154,614      
Exercise of stock options 638   638    
Exercise of stock options, shares   492,064      
Release of Restricted Stock Units, shares   4,014      
Stock compensation expense 2,289   2,289    
Net loss (11,792)       (11,792)
Foreign currency translation adjustments 1,859     1,859  
Net unrealized gain on investments (net of tax) 0        
Ending balance at Mar. 31, 2022 183,201 $ 15 441,623 2,591 (261,028)
Ending balance, shares at Mar. 31, 2022   151,650,692      
Beginning balance at Dec. 31, 2022 $ 110,123 $ 16 455,751 (6,997) (338,647)
Beginning balance, shares at Dec. 31, 2022   155,737,999      
Exercise of stock options, shares 0        
Release of Restricted Stock Units, shares   2,089,229      
Stock compensation expense $ 2,646   2,646    
Conversion of warrants to common stock 286   286    
Conversion of warrants to common stock, shares   277,828      
Net loss (17,673)       (17,673)
Foreign currency translation adjustments (1,589)     (1,589)  
Net unrealized gain on investments (net of tax) 44     44  
Ending balance at Mar. 31, 2023 $ 93,837 $ 16 $ 458,683 $ (8,542) $ (356,320)
Ending balance, shares at Mar. 31, 2023   158,105,056